Geographic differences in the incidence of cytogenetic abnormalities of acute myelogenous leukemia (AML) in Spain

Leukemia Research

Volumn 30, Issue 8, 2006, Pages 943-948

  Sierra, Magdalena ^a,b   Alonso, Álvaro ^c   Odero, M Dolores ^c   Gonzalez, M Belén ^a,b   Lahortiga, Idoia ^c   Pérez, José J ^a,b   García, Juan L ^a,b   Gutiérrez, Norma C ^a,b   Calasanz, María J ^c   San Miguel, Jesús F ^a,b   Hernández, Jesús M ^a,b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b Centro de Investigacion del Cancer   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

AML; Differences; Incidence; Karyotype

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CHROMOSOME STRUCTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; NUMERICAL CHROMOSOME ABERRATION; PRIORITY JOURNAL; SPAIN; TRISOMY 8;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 17; CYTOGENETIC ANALYSIS; FEMALE; GENETICS, POPULATION; GEOGRAPHY; HUMANS; KARYOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; SPAIN;

EID: 33744810086     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.12.025     Document Type: Article

References (25)

1. Nakase K., Bradstock K., Sartor M., Gottlieb D., Byth K., Kita K., et al. Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: a comparative study of Australian and Japanese adult cases. Leukemia 14 1 (2000) 163-168
2. Douer D. The epidemiology of acute promyelocytic leukaemia. Best Pract Res Clin Haematol 16 3 (2003) 357-367
3. Sandler D.P. Epidemiology of acute myelogenous leukemia. Semin Oncol 14 4 (1987) 359-364
4. Sandler D.P. Recent studies in leukemia epidemiology. Curr Opin Oncol 7 1 (1995) 12-18
5. Sandler D.P. Epidemiology and etiology of leukemia. Curr Opin Oncol 2 1 (1990) 3-9
6. Sandler D.P., and Ross J.A. Epidemiology of acute leukemia in children and adults. Semin Oncol 24 1 (1997) 3-16
7. Pulsoni A., Stazi A., Cotichini R., Allione B., Cerri R., Di Bona E., et al. Acute promyelocytic leukaemia: epidemiology and risk factors. A report of the GIMEMA Italian archive of adult acute leukaemia. GIMEMA Cooperative Group. Eur J Haematol 61 5 (1998) 327-332
8. Douer D., Preston-Martin S., Chang E., Nichols P.W., Watkins K.J., and Levine A.M. High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia. Blood 87 1 (1996) 308-313
9. Sekeres M.A., Peterson B., Dodge R.K., Mayer R.J., Moore J.O., Lee E.J., et al. Differences in prognostic factors and outcomes in African-Americans and Caucasians with acute myeloid leukemia. Blood (2004)
10. Johansson B., Mertens F., and Mitelman F. Geographic heterogeneity of neoplasia-associated chromosome aberrations. Genes Chromosomes Cancer 3 1 (1991) 1-7
11. Chillon C.M., Garcia-Sanz R., Balanzategui A., Ramos F., Fernandez-Calvo J., Rodriguez M.J., et al. Molecular characterization of acute myeloblastic leukemia according to the new WHO classification: a different distribution in Central-West Spain. Haematologica 86 2 (2001) 162-166
12. Ruiz-Arguelles G.J. Promyelocytic leukemia in Mexican Mestizos. Blood 89 1 (1997) 348-349
13. Estey E., Thall P., Kantarjian H., Pierce S., Kornblau S., and Keating M. Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia. Leukemia 11 10 (1997) 1661-1664
14. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., et al. Proposals for the classification of the acute leukaemias French-American-British (FAB) co-operative group. Br J Haematol 33 4 (1976) 451-458
15. ISCN. In: Mitelman F. (Ed). An international system for human cytogenetic nomenclature (1995), S. Karger, Basel
16. Slovak M.L., Kopecky K.J., Cassileth P.A., Harrington D.H., Theil K.S., Mohamed A., et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 96 13 (2000) 4075-4083
17. Grimwade D., Walker H., Oliver F., Wheatley K., Harrison C., Harrison G., et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 92 7 (1998) 2322-2333
18. Hernandez J.M., Gonzalez M.B., Granada I., Gutierrez N., Chillon C., Ramos F., et al. Detection of inv(16) and t(16;16) by fluorescence in situ hybridization in acute myeloid leukemia M4Eo. Haematologica 85 5 (2000) 481-485
19. Byrd J.C., Mrozek K., Dodge R.K., Carroll A.J., Edwards C.G., Arthur D.C., et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 100 13 (2002) 4325-4336
20. Grimwade D., Walker H., Harrison G., Oliver F., Chatters S., Harrison C.J., et al. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 98 5 (2001) 1312-1320
21. Wolman S.R., Gundacker H., Appelbaum F.R., and Slovak M.L. Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: a Southwest Oncology Group study. Blood 100 1 (2002) 29-35
22. Schoch C., Schnittger S., Klaus M., Kern W., Hiddemann W., and Haferlach T. AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Blood 102 7 (2003) 2395-2402
23. Nguyen S., Leblanc T., Fenaux P., Witz F., Blaise D., Pigneux A., et al. A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup. Blood 99 10 (2002) 3517-3523
24. Ferrara F., and Del Vecchio L. Acute myeloid leukemia with t(8;21)/AML1/ETO: a distinct biological and clinical entity. Haematologica 87 3 (2002) 306-319
25. Delaunay J., Vey N., Leblanc T., Fenaux P., Rigal-Huguet F., Witz F., et al. Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup. Blood 102 2 (2003) 462-469